688410.SHG SWS Hemodialysis Care Co. Ltd. A
- Market cap
- CNY 4.65B
- P/E
- 22.6x
- P/B
- 2.54x
- ROE
- 11.8%
- Dividend yield
- 0.69%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 688410.SHG undervalued?
Graham number688410.SHG trades 59.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SWS Hemodialysis Care Co. Ltd. A fundamental analysis
No fundamental analysis for SWS Hemodialysis Care Co. Ltd. A yet.
SWS Hemodialysis Care Co. Ltd. A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SWS Hemodialysis Care Co. Ltd. A
SWS Hemodialysis Care Co., Ltd. research, develops, produces, and sells blood purification equipment and consumables in China and internationally. It offers blood purification equipment, dialysis disposables, and dialysis center intelligent management system, as well as operates chain dialysis centers. The company was founded in 2001 and is headquartered in Chongqing, China.
Full company profileSWS Hemodialysis Care Co. Ltd. A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SWS Hemodialysis Care Co. Ltd. A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 254M | 283M | 382M | 690M | 567M | 807M | 982M |
| Gross Profit | 107M | 115M | 167M | 345M | 257M | 405M | 535M |
| Operating Income | 25.4M | 28.8M | 64.7M | 192M | 60.8M | 183M | 228M |
| EBITDA | - | - | 81.0M | 239M | 90.3M | 187M | 238M |
| Net Income | 20.6M | 19.5M | 59.2M | 194M | 70.9M | 146M | 212M |
| EPS | 0.09 | 0.08 | 0.18 | 0.61 | 0.22 | 0.46 | 0.47 |
| Balance Sheet | |||||||
| Total Assets | 608M | 556M | 1.93B | 1.94B | 2.01B | 2.35B | 2.42B |
| Total Liabilities | 239M | 166M | 410M | 240M | 333M | 568M | 632M |
| Shareholders' Equity | 365M | 387M | 1.52B | 1.70B | 1.69B | 1.78B | 1.79B |
| Cash & Short-term Investments | 145M | 172M | 1.44B | 772M | 631M | 573M | 534M |
| Cash Flow | |||||||
| Operating Cash Flow | -18.6M | 32.8M | 246M | 64.6M | 143M | 308M | - |
| Capital Expenditure | 22.9M | 28.1M | 12.9M | 113M | 83.2M | 156M | 299M |
| Free Cash Flow | -41.5M | 4.69M | 233M | -48.0M | 60.0M | 152M | -74.1M |
| Ratios | |||||||
| ROE | 5.6% | 5.0% | 3.9% | 11.5% | 4.2% | 8.2% | 11.8% |
| ROA | 3.4% | 3.5% | 3.1% | 10.0% | 3.5% | 6.2% | 8.7% |
| Net Profit Margin | 8.1% | 6.9% | 15.5% | 28.2% | 12.5% | 18.1% | 21.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
SWS Hemodialysis Care Co. Ltd. A dividends
- Dividend yield
- 0.69%
- Forward dividend
- 0.40 CNY
- Payout ratio
- 21.9%
- Ex-dividend date
- Sep 30, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 32.0M | 0.10 | 21.9% |
| 2024 | CNY 43.1M | 0.13 | 60.8% |
| 2023 | CNY 29.1M | 0.09 | 15.0% |
| 2022 | CNY 745K | 0.00 | 1.3% |
| 2021 | CNY 1.78M | 0.01 | 9.1% |
| 2020 | CNY 2.89M | 0.01 | 14.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jul 10, 2026.
Who owns SWS Hemodialysis Care Co. Ltd. A
- Insiders 42.02%
- Institutions 18.24%
- Public & others 39.74%
- Shares outstanding 447M
- Free float 202M
SWS Hemodialysis Care Co. Ltd. A company profile
- Company name
- SWS Hemodialysis Care Co. Ltd. A
- Ticker
- 688410.SHG
- ISIN
- CNE100005VK9
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,256
- Fiscal year end
- December
- Address
- No.1 Ciji Road, Chongqing, China, 401123
- Phone
- 86 23 6888 4702
- Website
- swskj.com
About SWS Hemodialysis Care Co. Ltd. A
SWS Hemodialysis Care Co., Ltd. research, develops, produces, and sells blood purification equipment and consumables in China and internationally. It offers blood purification equipment, dialysis disposables, and dialysis center intelligent management system, as well as operates chain dialysis centers. The company was founded in 2001 and is headquartered in Chongqing, China.
SWS Hemodialysis Care Co. Ltd. A management
6- Mr. Guangyong GaoGM & Chairman of the Board · born 1969
- Ms. Shangling YuDeputy GM, Secretary, CFO & Director · born 1975
- Mr. Yingxiang RenDeputy GM & Director · born 1976
- Mr. Jin TongDeputy GM & Employee Director · born 1982
- Ms. Chun Yan DuanDeputy General Manager · born 1977
- Wei Wei ZhangAccounting Supervisor